An experiment was designed to determine whether the pars tuberalis is the site of action of melatonin involved in the photoperiodic control of LH and prolactin secretion in sheep. In an attempt to produce a 'short-day' effect on these hormones (i.e. stimulation of LH secretion and inhibition of prolactin release), microimplants of melatonin were placed either around the pituitary stalk (n = 6) or in the third ventricle (n = 5) as a control for the efficacy of the microimplant. Two sham-operated groups were treated with empty microimplants around the pituitary stalk (n = 4) or in the third ventricle (n = 3). A further two control groups were given either no melatonin (n = 5) or a melatonin implant s.c. (n = 6). Administration of a melatonin implant s.c. is known to stimulate LH secretion and inhibit prolactin release in photoperiodically inhibited ewes. During the experiment (over 75 days), there was no significant increase in LH concentrations for the ewes receiving melatonin around the pituitary stalk. A similar lack of response was noted in the untreated or sham-treated ewes. In contrast, LH concentrations increased in ewes treated with the melatonin microimplant in the third ventricle on day 37 (\ m=+-\4) and remained high until day 62 (\m=+-\4). Similarly, in the ewes given an implant s.c., LH concentrations rose on day 39 (\m=+-\4) and remained high until the end of the study. Furthermore, melatonin caused an inhibition of prolactin secretion relative to controls only when delivered to these sites (i.e. s.c. and into the third ventricle, but not around the pituitary stalk). These results do not support the hypothesis that the pars tuberalis is a site of action of melatonin involved in the photoperiodic control of gonadotrophin or prolactin secretion in ewes.
Introduction
Reproduction in many breeds of sheep is under the influence of daylength (Yeates, 1949; Karsch et al, 1984; Ortavant et al, 1985) . Photoperiodic information is transduced to the hypothalamo-hypophysial axis by the pineal gland through its light-regulated secretion of melatonin (Bittman et al, 1983; Bittman and Karsch, 1984) . Melatonin is secreted with a marked day-night rhythm of secretion; in sheep, secretion occurs during the night (Karsch et al, 1985; Malpaux et al, 1987 Malpaux et al, , 1988 . The effects of melatonin on reproduction are mediated through changes in the pulsatile secretion of LHRH (Viguié et al, 1993) . Ovariectomized and oestradiol-treated ewes exposed to long days are characterized by a low frequency of LHRH discharge (about one pulse every 6 h). However, when treated with a melatonin implant, which causes a short-day effect (O'Callaghan et al, 1991) , the frequency of LHRH pulses increases to about 10 pulses per 6 h (Viguié et al, 1993) . This change in LHRH pulsatile secretion induces, in turn, variations in LH secretion (Bittman et al, 1985) , which are responsible for the alternating presence or absence of ovula-tions in intact ewes (Karsch et al, 1984; Malpaux et al, 1993a) .
The mechanisms by which melatonin exerts this action on the system generating LHRH pulses are unknown.
Recently, binding sites for melatonin have been localized in several neuroendocrine tissues (Bittman and Weaver, 1990;  de Reviers et al, 1991) . In sheep, as in all other species studied, the highest density of these sites has been found in the pars tuberalis of the pituitary gland (de Reviers et al, 1989;  Morgan et al, 1989; Bittman and Weaver, 1990; Stankov et al, 1991) .
However, it remains to be determined whether these binding sites are those by which melatonin exerts its influence on LH secretion. The use of melatonin microimplants positioned in different areas of the ewe brain has revealed that melatonin stimulates neuroendocrine reproductive activity only when the implants are placed in the mediobasal hypothalamus. The implants are ineffective when placed in the preoptic area, the dorsolateral hypothalamus or the anterior hypothalamus (Malpaux et al, 1990 (Malpaux et al, , 1993b . Similarly, in rams, melatonin microimplants stimulate the reproductive axis when placed in the mediobasal hypothalamus, but not in the preoptic area (Lincoln and Maeda, 1992a, b) .
A possible explanation for the discrepancy between the location of binding sites and the site of activity could be that when melatonin is released from the mediobasal hypothalamus microimplants, it is transported to the pars tuberalis. To test the importance of the pars tuberalis in mediating LH secretion, we assessed the effect of melatonin microimplants directly apposed to the pituitary stalk on LH and prolactin secretion. Results were compared with those from identical microimplants inserted into the third ventricle that allowed melatonin to reach periventricular sites, including the mediobasal hypothalamus and the pars tuberalis (Fitzgerald, 1979; Bouchard and Bosler, 1986 ). If the pars tuberalis is the site of action of melatonin, a stronger or identical response should be observed when melatonin is delivered directly to it compared with melatonin microimplants inserted into the third ventricle.
Materials and Methods

Design
Studies were performed on ovariectomized and oestradioltreated ewes maintained as described by Malpaux et al (1993b).
Preliminary experiment: tissue content of melatonin in the pituitary stalk of implanted animals. To determine whether melatonin microimplants apposed to the pituitary stalk could increase the daytime concentrations of melatonin within this tissue, at least relative to concentrations observed at night, two ewes received melatonin microimplants apposed to the pitu¬ itary stalk. Fourteen days later, they were killed at 12:00 h by decapitation and the brain, the pituitary stalk and a part of the pituitary were removed from the skull. The pituitary stalk was then divided into four pieces by a mid-coronal and then a mid-horizontal incision to give anteroventral, anterodorsal, posteroventral and posterodorsal fragments. Similarly sized tissue samples were also obtained from the pars distalis of the pituitary and the infundibulum of the hypothalamus. These different samples were homogenized in 70 µ PBS and mela¬ tonin was extracted with 1 ml chloroform. The chloroform extract was dried under a stream of nitrogen and the residue was resuspended in 700 µ of tricine buffer (pH 5.5; 0.1 mol 1 "*). Melatonin was assayed in duplicate aliquots of 300 µ , as described below. The pellets remaining after chloroform extrac¬ tion were used to determine the protein content according to the methods of Bradford (1976).
Main experiment: comparison of the effects of melatonin microimplants directly apposed to the pituitary stalk or inserted in the third ventricle. Twenty-nine ewes were allocated at random to one of six groups to compare the effects of melatonin implanted in the third ventricle or around the pituitary stalk. All ewes that had been previously maintained under a shortday photoperiod (8 h light: 16 h dark; lights on at 06.00 h) were exposed to long days (16 h light:8 h dark; lights on at 06.00 h) from 20 February until the end of the experiment. Two groups of ewes (n = 5 and 6, respectively) were used as controls: the first did not receive any melatonin treatment (nonoperated control) while the other was given a melatonin implant s.c. on 22 May (after 89 long days). Two groups received a micro-implant of melatonin either around the pituitary stalk (n = 6) or in the third ventricle (n = 5) and two other groups (shamoperated) received empty implants in those two sites (n = 4 and 3, respectively). Because of the limitation due to surgery, these implantations were not performed on the same day but over the course of a week (15-22 May). For each ewe, the onset of treatment was considered as day 0 of experiment (day 0 of nonoperated and animals implanted s.c. was 22 May). One animal from the group with an implant inserted into the third ventricle group died 10 days after the surgery. Blood samples were obtained twice a week between 14:00 h and 16:00 h to assess the effects of the treatments on LH secretion. In addition, the effect of the microimplants on prolactin secretion was determined by collecting blood samples every hour for 24 h starting at 09:00 h on two separate occasions before and after the onset of the experiment (on day -16 and day 26 on average). The first four samples obtained on each occasion were not assayed to avoid the interference of feeding and stress-associated initiation of bleeding on prolactin secretion.
Eight samples obtained on the second occasion (14 June) were also assayed for melatonin to assess whether the implants modified circulating melatonin concentrations. The samples analysed were those obtained every other hour between 19:00 and 09:00 h.
Melatonin implants
Microimplants were made from commercial implants gener¬ ously provided by Sanofi (Libourne). These cylindrical implants contain melatonin and Silastic (Dow Coming, MI) and have outside diameter: 2.5 mm; length: 15 mm. Under a dissecting microscope, the cylinder was cut into 1.5 mm lengths. The centre of each cylinder was then removed to create an inside diameter of 1.5 mm. Finally, each cylinder was cut in half and each half was used as a curved microimplant.
The delivery rate of these implants was measured in vitro by incubation in 500 ml of saline at 37°C After an initial peak (10-20 µg per day), the rate of release stabilized after 1 week at 5.2 ± 0.2 µg per day (n = 3). Subcutaneous implants were made from a 5 cm2 envelope of Silastic sheeting (0.13 mm wide, Dow Corning) containing 1 g of melatonin (English et al, 1986) . The implants were inserted s.c. in the inner part of a back leg under local anaesthesia (2 ml Sylvocaine, Rhône-Mérieux, Lyon).
Surgery and location of implants
Surgery was performed under general anaesthesia as described by Malpaux et al (1993b).
Microimplants were positioned around the pituitary stalk using the transnasal approach described by Caraty and Locatelli (1988) for cannulation of the hypothalamo-hypophysial portal vessels. Briefly, a tunnel was opened through the sphenoid bone and the dura was opened in front of the portal vessels. A retractor was positioned to lift the optic chiasm, which enabled visualization of the whole pituitary stalk. The microimplant was positioned around the anteroventral face of the pituitary stalk. After placing the microimplant, the dura was replaced and held in position by gel foam (Spongel: Distriphar, Aulnaysous-Bois). The tunnel within the sphenoid bone was then filled with dental acrylic, the bone plate replaced and the skin sutured.
To insert melatonin microimplants in the third ventricle, a guide cannula (outside diameter: 18 mm; inside diameter: 14 mm) was first positioned in this ventricle using the pro¬ cedure of Blanc et al (1992) . The melatonin microimplant was forced down the cannula into the ventricle. The cannula was then removed and the skull sealed as described by Malpaux et al (1993b).
To localize the implants at the end of the experiment, animals were killed by decapitation. Their heads were immedi¬ ately perfused via the carotid arteries with 2 1 of 4% formal¬ dehyde in phosphate buffer (pH 7.4; 0.1 mol 1~* ). For animals with implants in the third ventricle, brains were removed and cut in the parasagittal plane. The pituitary stalk implants were located by carefully removing the brain with the hypophysis and part of the sphenoid bone still attached. The sphenoid bone was carefully dissected until the implant was located.
Blood sampling and assays
Blood samples were obtained from the right jugular vein by venepuncture; plasma was separated and stored at -20°C until assayed. LH was assayed in duplicate aliquots of 100 µ of plasma using the radioimmunoassay of Pelletier et al. (1968), modified by Montgomery et al (1985) . Sensitivity (2 SDs from buffer controls) was 0.14 ± 0.01 ng ml-1 (mean ± SEM, five assays) of 1051-CY-LH (i.e. 0.29 ng ml" 1 of NIH-LH-Sl). The intra-assay coefficient of variation for five plasma pools aver¬ aged 6.6% (five assays); the interassay coefficient of variation for these plasma pools averaged 11.4%.
Prolactin was assayed in duplicate aliquots of 10 µ of plasma using the radioimmunoassay of Kann (1971) . Sensitivity was 14 ng ml"1 of NIDDK-oPRL-19 for 10 µ . All samples were analysed in a single assay; the intra-assay coefficient of variation for three plasma pools averaged 7.4%.
Melatonin was assayed in duplicate aliquots of 100 µ of plasma by the radioimmunoassay of Fraser et al. (1983) , using an antibody first raised by Tillet et al (1986) . Sensitivity was 9 pg ml~1 (one assay). All samples were analysed in a single assay; the intra-assay coefficient of variation for two plasma pools averaged 15%.
Statistical analyses
For each ewe, the LH basal value was defined as the average of the LH concentrations between day -32 and day 0, when all animals were kept under a long-day photoperiod (seven samples). The time when circulating LH concentrations started to rise was determined by the first of at least three consecutive values exceeding the LH basal value by more than 3 SDs of this baseline. For the ewes that did not show an increase in LH secretion during the experiment, this time was set to 75 days (end of experiment). The amplitude of the LH rise was defined as the highest mean of three consecutive values. These times of increase and the amplitudes of the LH rise were then analysed by the Mann-Whitney two-sample rank test.
Prolactin values were analysed by a three-factor analysis of variance (treatment as a between-test factor, time of day and time relative to treatment as within-test factors). Interactions between treatment and time relative to treatment were further analysed by a one-factor ANOVA (treatment) on the differences between prolactin values before and after treatment. A Duncan's new multiple range test was then used to determine differences between treatments. For each animal, the difference between the mean prolactin concentrations (throughout the day) before and after the onset of treatments was calculated and was used for the expression of results.
Results
Preliminary experiment; tissue content of melatonin in the pituitary stalk of implanted animals In the two ewes killed 14 days after insertion of a melatonin microimplant around the pituitary stalk, the mean tissue concentrations of melatonin were 127.7, 45.5, 154.3 and 64.1 pg mg"1 protein in the anteroventral, anterodorsal, posteroventral and posterodorsal parts, respectively, of the pituitary stalk. In the infundibular hypothalamus and the pars distalis, melatonin concentrations in implanted ewes were 10.1 and 33.2 pg mg~ protein, respectively.
Main experiment: comparison of the effects of melatonin microimplants directly apposed to the pituitary stalk or inserted within the third ventricle Effects of melatonin on LH secretion. In nonoperated control animals, LH concentrations were low at the beginning (0.5-0.7 ng ml-1) and remained at basal values until the end of the study (day 75). LH concentrations in sham-operated animals also remained uniformly low until the end of the study, except for a single increase in LH (day 60) in one of the animals sham-operated in the pituitary stalk (Figs 1 and   2 ). Melatonin caused a stimulation of LH secretion in the group given an implant in the third ventricle (P < 0.01), as all animals from that group displayed an increase in LH se¬ cretion on day 37 + 4; LH concentrations remained high until day 62 ± 4. In contrast, the concentration of LH remained at basal values throughout the study in all animals from the group given an implant around the pituitary stalk. All animals from the group with an s.c. implant of melatonin showed an increase in LH secretion, the onset of which was not different from that of the third ventricle group (day 39 ±4). However, this increase lasted longer (P<0.01); LH was still high at the end of the study (day 75). The amplitude of the increase was larger in the group given the s.c. implant than in the group given the implant in the third ventricle (4.8 ±0.7 versus 1.6 ± 0.2 ng ml " ; < 0.01).
Effects of melatonin on prolactin secretion. In nonoperated and sham-operated animals, prolactin concentrations decreased between the two times of blood collection by 58 ± 20 and 46 ± 16 ng ml " , respectively (Fig. 3 ). In the group given the implant around the pituitary stalk, the decrease in the Day of experiment Fig. 1 . Mean ( ± SEM) values of LH concentrations in control ewes ( ; five nonoperated and seven sham-operated, repeated in the three panels) and ( ) in animals that had received a microimplant of melatonin in the third ventricle (a, = 4), around the pituitary stalk (b, -6) and s.c. (c, = 6). All ewes were ovariectomized and treated with oestradiol administered via an s.c. implant. Blood samples were obtained twice a week. LH values were calculated after logarithmic transformations and plotted on a logarithmic scale. Melatonin treat¬ ment started on day 0. concentration of prolactin was not different from that of controls (75 ± 21 ng ml"1). In contrast, the decrease in pro¬ lactin was higher in the groups given the implant in the third ventricle and s.c. (124 ± 16 and 130 + 25 ng ml"1, respec¬ tively; < 0.05). Profiles of prolactin secretion from 13:00 to 09:00 h on the two occasions of blood sampling for one representative animal from each group are shown (Fig. 4 ).
Prolactin concentrations varied with time of day (P < 0.001); a large increase occurred after the lights had been switched off. This increase tended to be smaller after treatment with melatonin implanted s.c. or into the third ventricle ( Fig. 4) . Plasma concentrations of melatonin. Whether they were inserted in the third ventricle or around the pituitary stalk, microimplants did not modify the profile of melatonin se¬ cretion compared with that of control animals (Fig. 5 ). Concentrations during the day remained undetectable ( < 9 pg ml~ ), while concentrations at night varied between 300 and 500 pg ml"1 in the two groups receiving microimplants, as in controls. In contrast, implants given s.c. induce a large increase in daytime melatonin concentrations (of about 200 pg ml~c ompared with controls). Concentrations during the night were also approximately 200 pg higher than in the control group.
Location of microimplants. The implants inserted into the third ventricle were found in the upper part of this cavity at the foramen of Monroe. For the pituitary stalk, implants were positioned directly against the pituitary stalk, just above the pituitary. (c, = 6). Lights were switched off at 22:00 h. Each value represents the reduction of prolactin concentrations between the measurements made before and after the onset of treatments.
Discussion
The results reported here indicate that microimplants of mela¬ tonin surrounding the anterior face of the pituitary stalk do not cause any detectable modification of LH and prolactin secretion in ewes. This finding is in sharp contrast to the increase in LH secretion and the decrease in prolactin secretion observed when the same microimplants are placed in the third ventricle, despite the dilution of melatonin in the cerebrospinal fluid.
Furthermore, it is also in contrast to the results obtained when melatonin was implanted s.c. As the pars tuberalis surrounds the pituitary stalk, it was reached directly (at least in its ventral portion) by melatonin released from the microimplants. These results, therefore, do not support the hypothesis that the pars tuberalis is a site of action for mediating melatonin effects on reproduction and prolactin secretion. In contrast, these results complement the observation that microimplants placed in the mediobasal hypothalamus of the ewe cause changes in the secretion of LH and prolactin (Malpaux et al, 1990, 1993b) . These studies suggested that the mediobasal hypothalamus was the critical site reached by sham-operated implant around the pituitary stalk before (o) and after (·) the onset of the treatments. D: difference in prolactin concen¬ trations averaged throughout the day between the two situations. melatonin released from the microimplants. In sheep, the melatonin released by implants is thought to cause a stimu¬ lation of LH secretion by providing a long-duration signal that mimics short days, rather than acting by masking the inhibitory effect of long days (O'Callaghan et al, 1991) . These data suggest, therefore, that the mediobasal hypothalamus is a critical target for melatonin in transducing the effect of photoperiod on LH secretion. The transnasal approach used in this experiment to position the microimplant against the pituitary offers two important advantages. First, it does not damage the tissue of interest. In contrast, insertion of a microimplant via a dorsal route into the pars tuberalis would potentially damage the hypothalamohypophysial portal blood system and the pars tuberalis itself. third ventricle). Hatched area depicts the period of darkness. Note that the microimplants in the third ventricle or the pituitary stalk did not cause any change in the melatonin profile. Error bars are not indicated for reasons of clarity.
Second and more importantly, the positioning of the microimplant after direct visualization of the pituitary stalk allows a better repeatability in the placement than a stereotaxic pro¬ cedure using ventricular landmarks. However, the drawback of this approach is that melatonin may not reach the pars tuberalis as easily as if it were delivered within this tissue. The results of our preliminary experiment indicate that the microimplants apposed to the pars tuberalis increased melatonin concen¬ trations within the different parts of the pituitary stalk. These concentrations are similar to those measured at night in untreated ewes. Indeed, in another experiment, we observed that the tissue concentration of melatonin in the whole pituitary stalk varied between 50 and 100 pg mg" protein in five ewes killed during the night; daytime concentrations varied between 2 and 4 pg mg~protein in three ewes killed during the day (B. Malpaux, A. Daveau and F. Maurice, unpublished). Melatonin released from the microimplants could therefore reach the pars tuberalis. Furthermore, since melatonin concentrations in the apposed pars tuberalis were similar to concentrations during the night, it also suggests that the experiment was performed in physiological conditions. Thus, the lack of effect of the microimplants does not seem to be the result of a desensitization of the tissue to supraphysio-Iogical amounts of melatonin. However, we cannot exclude this as a possibility and experiments are in progress to determine whether animals with implants in the pars tuberalis are desensitized to melatonin.
An interesting observation in this study is the weak response observed in the ewes given the implants in the third ventricle compared with those given s.c. Both the duration and the amplitude of the LH rise were smaller than those measured after s.c. treatment. This could result from a limited release of melatonin from the microimplant. A dose-dependent effect of continuous melatonin administration on ovulation rate in ewes has been demonstrated (Williams et al, 1986 ), suggesting an effect of the dose of melatonin on the amplitude of the reproductive response. However, the timing of the onset of the response in the third ventricle was similar to that of the group treated s.c. and of short-day responses previously observed in that model (Malpaux et al, 1993b) , indicating that melatonin microimplanted into the third ventricle provided the same timing signal. Furthermore, this limited release is probably more crucial for the group with implants in the third ventricle, in which melatonin was diluted in the cerebrospinal fluid before reaching the targeted site, than in the group with implants around the pars tuberalis, where it was delivered directly to the targeted site. Nevertheless, a response was obtained in the group with an implant in the third ventricle and not in ewes with implants around the pars tuberalis.
Melatonin also mediates the effects of photoperiod on prolactin secretion in ewes (Thimonier et al, 1978; Poulton et al, 1986) . Treatment with a melatonin implant s.c. causes an inhibition of prolactin secretion (Malpaux et al, 1993b) . Mela¬ tonin microimplants positioned in different brain areas have revealed that melatonin inhibits prolactin secretion only when the implants are placed in the mediobasal hypothalamus (Lincoln and Maeda, 1992b; Malpaux et al, 1993b) . However, these results did not exclude an action of melatonin in the pars tuberalis in controlling prolactin secretion. In the present study, the action of melatonin microimplants on prolactin secretion is consistent with that seen for LH. A decrease in prolactin concentration was observed in all groups but it was larger than in controls only in the groups given implants in the third et al, 1992) from which the LHRH-stimulated secretion of LH can be inhibited by melatonin in vitro (Skinner and Robinson, 1993) . It is possible that LH released from the pars tuberalis could act on the hypothalamus to modulate the release of LHRH by a short-loop feedback mechanism (Nakazawa et al, 1991) . However, this feedback action of LH would not explain the regulation of functions other than reproduction by mela¬ tonin. Furthermore, it is difficult to reconcile this short-term action (less than 1 h) of melatonin on gonadotrophs in the pars tuberalis with the effect of melatonin on LH secretion in vivo, which takes 40-50 days to develop. Nevertheless, the ability of melatonin to modulate this response of the pars tuberalis to LHRH may be supplementary to the major action of melatonin, which would be to control LHRH pulse frequency at a hypothalamic site. Indeed, previous studies have suggested that the mediobasal hypothalamus may be the crucial target site for melatonin. Moreover, there is evidence that melatonin binding sites are present in the mediobasal hypothalamus of sheep, particularly in the vicinity of the ventromedial nucleus (Bittman and Weaver, 1990; de Reviers et al, 1991; Helliwell and Williams, 1992) .
In conclusion, our results suggest that the pars tuberalis is not a site of action of melatonin involved in the control of gonadotrophin and prolactin secretion in ewes. This finding supports our previous studies, which indicate that the mediobasal hypothalamus is the crucial target for transducing the reproductive effects of melatonin. Additional work is in progress to investigate this hypothesis. 
